Development and External Validation of a Nomogram to Predict Cancer-Specific Survival in Patients with Primary Intestinal Non-Hodgkin Lymphomas

References

• Gou HF, Zang J, Jiang M, et al. Clinical prognostic analysis of 116 patients with primary intestinal non-Hodgkin lymphoma. Med Oncol. 2012;29(1):227–234. doi:10.1007/s12032-010-9783-x21193968
   PubMed Web of Science ®Google Scholar
• Tian C, Li Y, Chen Z. A retrospective analysis of primary gastrointestinal non-Hodgkin lymphomas: clinical features, prognostic factors and treatment outcomes. Onco Targets Ther. 2020;13:5345–5352. doi:10.2147/OTT.S24838132606752
   PubMed Web of Science ®Google Scholar
• Aviles A, Neri N, Nambo MJ, et al. Surgery and chemotherapy versus chemotherapy as treatment of high-grade MALT gastric lymphoma. Med Oncol. 2006;23(2):295–300. doi:10.1385/MO:23:2:29516720930
   PubMed Web of Science ®Google Scholar
• Ikoma N, Badgwell BD, Mansfield PF. Multimodality treatment of gastric lymphoma. Surg Clin North Am. 2017;97(2):405–420. doi:10.1016/j.suc.2016.11.01228325194
   PubMed Web of Science ®Google Scholar
• Wang W, Lin P, Yao H, et al. Clinical analysis of primary gastrointestinal non-Hodgkin’s lymphoma. Pak J Med Sci. 2017;33(6):1406–1411. doi:10.12669/pjms.336.1363129492068
   PubMed Web of Science ®Google Scholar
• Lu J, Tan H, Li B, et al. Status and prognostic nomogram of patients with Burkitt lymphoma. Oncol Lett. 2020;19(1):972–984. doi:10.3892/ol.2019.1115531897210
   PubMed Web of Science ®Google Scholar
• Jiang S, Qin Y, Liu P, et al. Prognostic nomogram and predictive factors in refractory or relapsed diffuse Large B-cell lymphoma patients failing front-line R-CHOP regimens. J Cancer. 2020;11(6):1516–1524. doi:10.7150/jca.3699732047558
   PubMed Web of Science ®Google Scholar
• Han Y, Yang J, Liu P, et al. Prognostic nomogram for overall survival in patients with diffuse Large B-Cell lymphoma. Oncologist. 2019;24(11):e1251–e1261. doi:10.1634/theoncologist.2018-036130952824
   PubMed Web of Science ®Google Scholar
• Li K, Wang R, Huang S, et al. Prognostic nomogram for overall survival in extranodal natural Killer/T-Cell Lymphoma patients. Clin Lymphoma Myeloma Leuk. 2018;18(12):e537–e543. doi:10.1016/j.clml.2018.08.01130243570
   PubMed Web of Science ®Google Scholar
• Zhu Y, Xu W, Zheng X, et al. Nomogram incorporating clinicopathological parameters to predict the survival of patients with mantle cell lymphoma. J Investig Med. 2019;67(2):331–337. doi:10.1136/jim-2018-000837
   PubMed Web of Science ®Google Scholar
• Sun B, Xia Y, Guo Y, et al. Development and validation of prognostic nomograms for patients with primary gastrointestinal Non-Hodgkin Lymphomas. Dig Dis Sci. 2020;65(12):3570–3582. doi:10.1007/s10620-020-06078-931993894
   PubMed Web of Science ®Google Scholar
• Wang J, Zhou M, Zhou R, et al. Nomogram for predicting the overall survival of adult patients with primary gastrointestinal diffuse Large B Cell Lymphoma: a SEER- Based Study. Front Oncol. 2020;10:(1093. doi:10.3389/fonc.2020.01093
   Web of Science ®Google Scholar
• Zhong Q, Shi Y. Development and validation of a novel risk stratification model for cancer-specific survival in diffuse Large B-Cell Lymphoma. Front Oncol. 2020;10:(582567. doi:10.3389/fonc.2020.582567
   Web of Science ®Google Scholar
• Lightner AL, Shannon E, Gibbons MM, et al. Primary gastrointestinal non-Hodgkin’s lymphoma of the small and large intestines: a Systematic Review. J Gastrointest Surg. 2016;20(4):827–839. doi:10.1007/s11605-015-3052-426676930
   PubMed Web of Science ®Google Scholar
• Touijer K, Scardino PT. Nomograms for staging, prognosis, and predicting treatment outcomes. Cancer. 2009;115(13 Suppl):3107–3111. doi:10.1002/cncr.2435219544538
   PubMed Web of Science ®Google Scholar
• Fang C, Wang W, Feng X, et al. Nomogram individually predicts the overall survival of patients with gastroenteropancreatic neuroendocrine neoplasms. Br J Cancer. 2017;117(10):1544–1550. doi:10.1038/bjc.2017.31528949958
   PubMed Web of Science ®Google Scholar
• Dong F, Shen Y, Gao F, et al. Nomograms to predict individual prognosis of patients with primary small cell carcinoma of the bladder. J Cancer. 2018;9(7):1152–1164. doi:10.7150/jca.2334429675096
   PubMed Web of Science ®Google Scholar
• Balachandran VP, Gonen M, Smith JJ, et al. Nomograms in oncology: more than meets the eye. Lancet Oncol. 2015;16(4):e173–80. doi:10.1016/S1470-2045(14)71116-725846097
   PubMed Web of Science ®Google Scholar
• Harrell FE Jr, Lee KL, Mark DB. Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med. 1996;15(4):361–387. doi:10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-48668867
   PubMed Web of Science ®Google Scholar
• Kumar R, Indrayan A. Receiver operating characteristic (ROC) curve for medical researchers. Indian Pediatr. 2011;48(4):277–287. doi:10.1007/s13312-011-0055-421532099
   PubMed Web of Science ®Google Scholar
• Vickers AJ, Elkin EB. Decision curve analysis: a novel method for evaluating prediction models. Med Decis Making. 2006;26(6):565–574. doi:10.1177/0272989X0629536117099194
   PubMed Web of Science ®Google Scholar
• Vickers AJ, Cronin AM, Elkin EB, et al. Extensions to decision curve analysis, a novel method for evaluating diagnostic tests, prediction models and molecular markers. BMC Med Inform Decis Mak. 2008;8:53. doi:10.1186/1472-6947-8-5319036144
   PubMed Web of Science ®Google Scholar
• Camp RL, Dolled-Filhart M, Rimm DL. X-tile: a new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization. Clin Cancer Res. 2004;10(21):7252–7259. doi:10.1158/1078-0432.CCR-04-071315534099
   PubMed Web of Science ®Google Scholar
• Pencina MJ, D’agostino RB Sr, D’agostino RB Jr, et al. Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med. 2008;27(2):157–72; discussion 207–12. doi:10.1002/sim.2929
   PubMed Web of Science ®Google Scholar
• Iasonos A, Schrag D, Raj GV, et al. How to build and interpret a nomogram for cancer prognosis. J Clin Oncol. 2008;26(8):1364–1370. doi:10.1200/JCO.2007.12.979118323559
   PubMed Web of Science ®Google Scholar
• International Non-Hodgkin’s Lymphoma Prognostic Factors P. A predictive model for aggressive non-Hodgkin’s lymphoma. N Engl J Med. 1993;329(14):987–994. doi:10.1056/NEJM1993093032914028141877
   PubMed Web of Science ®Google Scholar
• Lugtenburg PJ, Lyon AR, Marks R, et al. Treatment of aggressive non-Hodgkin’s lymphoma in frail patients: cardiac comorbidities and advanced age. Future Oncol. 2019;15(11):1197–1205. doi:10.2217/fon-2019-001930730219
   PubMed Web of Science ®Google Scholar
• Li M, Han M, Chen Z, et al. Does marital status correlate with the female breast cancer risk? A systematic review and meta-analysis of observational studies. PLoS One. 2020;15(3):e0229899. doi:10.1371/journal.pone.022989932134997
   PubMed Web of Science ®Google Scholar
• Trudel-Fitzgerald C, Poole EM, Sood AK, et al. Social integration, marital status, and ovarian cancer risk: a 20-year prospective Cohort Study. Psychosom Med. 2019;81(9):833–840. doi:10.1097/PSY.000000000000074731592935
   PubMed Web of Science ®Google Scholar
• Lau SKM, Gannavarapu BS, Carter K, et al. Impact of socioeconomic status on pretreatment weight loss and survival in non-small-cell lung cancer. J Oncol Pract. 2018;14(4):e211–e220. doi:10.1200/JOP.2017.02523929558251
   PubMed Web of Science ®Google Scholar
• Osazuwa-Peters N, Christopher KM, Cass LM, et al. What’s Love Got to do with it? Marital status and survival of head and neck cancer. Eur J Cancer Care (Engl). 2019;28(4):e13022. doi:10.1111/ecc.1302230784126
   PubMed Web of Science ®Google Scholar
• Celeng C, Takx R, Lessmann N, et al. The association between marital status, coronary computed tomography imaging biomarkers, and mortality in a lung cancer screening population. J Thorac Imaging. 2020;35(3):204–209. doi:10.1097/RTI.000000000000045731651690
   PubMed Web of Science ®Google Scholar
• Yang CC, Cheng LC, Lin YW, et al. The impact of marital status on survival in patients with surgically treated colon cancer. Medicine. 2019;98(11):e14856. doi:10.1097/MD.000000000001485630882684
   PubMed Web of Science ®Google Scholar
• Buja A, Lago L, Lago S, et al. Marital status and stage of cancer at diagnosis: a systematic review. Eur J Cancer Care (Engl). 2018;27(1):e12755. doi:10.1111/ecc.12755
   Web of Science ®Google Scholar
• Le Guyader-peyrou S, Orazio S, Dejardin O, et al. Factors related to the relative survival of patients with diffuse large B-cell lymphoma in a population-based study in France: does socio-economic status have a role? Haematologica. 2017;102(3):584–592. doi:10.3324/haematol.2016.15291827909221
   PubMed Web of Science ®Google Scholar
• Aizer AA, Chen MH, Mccarthy EP, et al. Marital status and survival in patients with cancer. J Clin Oncol. 2013;31(31):3869–3876. doi:10.1200/JCO.2013.49.648924062405
   PubMed Web of Science ®Google Scholar
• Gallo LC, Troxel WM, Matthews KA, et al. Marital status and quality in middle-aged women: associations with levels and trajectories of cardiovascular risk factors. Health Psychol. 2003;22(5):453–463. doi:10.1037/0278-6133.22.5.45314570528
   PubMed Web of Science ®Google Scholar
• Olszewska-Szopa M, Wrobel T. Gastrointestinal non-Hodgkin lymphomas. Adv Clin Exp Med. 2019;28(8):1119–1124. doi:10.17219/acem/9406831414733
   PubMed Web of Science ®Google Scholar
• Anderson T, Chabner BA, Young RC, et al. Malignant lymphoma. 1. The histology and staging of 473 patients at the National Cancer Institute. Cancer. 1982;50(12):2699–2707. doi:10.1002/1097-0142(19821215)50:12<2699::aid-cncr2820501202>3.0.co;2-A7139563
   PubMed Web of Science ®Google Scholar
• Azab MB, Henry-Amar M, Rougier P, et al. Prognostic factors in primary gastrointestinal non-Hodgkin’s lymphoma. A multivariate analysis, report of 106 cases, and review of the literature. Cancer. 1989;64(6):1208–1217. doi:10.1002/1097-0142(19890915)64:6<1208::aid-cncr2820640608>3.0.co;2-z2670184
   PubMed Web of Science ®Google Scholar
• Coffey J, Hodgson DC, Gospodarowicz MK. Therapy of non-Hodgkin’s lymphoma. Eur J Nucl Med Mol Imaging. 2003;30 Suppl 1:S28–S36. doi:10.1007/s00259-003-1157-612692688
   PubMed Web of Science ®Google Scholar
• Kim SJ, Choi CW, Mun YC, et al. Multicenter retrospective analysis of 581 patients with primary intestinal non-Hodgkin lymphoma from the Consortium for Improving Survival of Lymphoma (CISL). BMC Cancer. 2011;11:321. doi:10.1186/1471-2407-11-32121798075
   PubMed Web of Science ®Google Scholar
• Eom BW, Ryu KW, Nam BH, et al. Survival nomogram for curatively resected Korean gastric cancer patients: multicenter retrospective analysis with external validation. PLoS One. 2015;10(2):e0119671. doi:10.1371/journal.pone.011967125723182
   PubMed Web of Science ®Google Scholar